Hilltop Holdings Inc. Moderna, Inc. Transaction History

Hilltop Holdings Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $12,073 - $17,534	-89 Reduced 5.91%	1,418 $217,000
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $178,398 - $316,530	1,507 New	1,507 $270,000
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $18,272 - $27,548	156 Added 10.77%	1,604 $229,000
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $275,176 - $511,468	-2,176 Reduced 60.04%	1,448 $250,000
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $171,397 - $279,699	-759 Reduced 17.32%	3,624 $921,000
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $203,704 - $444,743	918 Added 26.49%	4,383 $1.69 Million
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $54,951 - $99,396	-423 Reduced 10.88%	3,465 $814,000
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $155,144 - $264,277	-1,421 Reduced 26.77%	3,888 $509,000
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $34,973 - $90,365	532 Added 11.14%	5,309 $555,000
Q3 2020 Nov 16, 2020	BUY	$54.34 - $94.85 $60,697 - $105,947	1,117 Added 30.52%	4,777 $338,000
Q2 2020 Aug 14, 2020	SELL	$29.67 - $80.0 $501,304 - $1.35 Million	-16,896 Reduced 82.19%	3,660 $235,000
Q1 2020 May 15, 2020	BUY	$17.78 - $31.58 $365,485 - $649,158	20,556 New	20,556 $616,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Hilltop Holdings Inc., based on Form 13F filings with the SEC.

Stay updated on Hilltop Holdings Inc. with notifications on news.